| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.2B | $0.1B | $0.1B | $0.2B | $0.1B | $0.0B | $0.0B | $0.0B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.0B | $-0.0B | $-0.0B | $-0.0B | $0.0B | $0.0B | $-0.0B | $0.0B |
| EPS (Basic) | $1.60 | $-0.57 | $-2.12 | $-0.70 | $0.09 | $0.13 | $-0.08 | $0.18 |
| EPS (Diluted) | $1.48 | $-0.57 | $-2.12 | $-0.70 | $0.09 | $0.13 | $-0.08 | $0.18 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $0.4B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.1B | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $-0.0B | $-0.0B | $0.0B | $-0.0B | $0.0B | $0.0B | $0.0B |
| Investing Cash Flow | $-0.0B | $0.0B | $-0.0B | $-0.0B | $0.0B | $-0.0B | $-0.0B | $-0.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | — | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $-0.0B | $0.1B |